Skip to main content

Advertisement

Table 2 Prediction of changes in CTX and P1NP using a general linear model

From: Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients

Variables CTX, pg/ml (330.759 ± 166.5) P1NP, pg/ml (160.703 ± 139.9)
P-valuea Partial Eta squared P-valuea Partial Eta squared
EPO < 0.0001 0.152 0.024 0.064
Estrogen or testosterone 0.029 0.060 0.816 0.001
OPG 0.335 0.012 0.009 0.083
RANKL 0.017 0.071 < 0.0001 0.194
  1. CTX carboxy terminal collagen cross links, P1NP N-terminal propeptide of type 1 collagen, EPO erythropoietin, OPG osteoprotegerin, RANKL receptor activator of NF-kappaB ligand
  2. aP-values were calculated by a general linear model with CTX and P1NP as outcome variables